Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Safe for all skin types when administered by medical professionals
It has been studied for its potential to aid in healing, reduce inflammation, and support overall recovery processes
Does the efficacy hold
We anticipate a myostatin inhibitor might launch as early as 2028 and could be priced at US$4,000 per year based on the current price of GLP-1 therapies and the anticipated future competitive pricing that will be offered
Rules apply irrespective of dosage or administration route
Among those not taking the medications, 13% said they were likely to start in the future
US$ 25.89
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 29.25
US$ 21.14
US$ 25.28
US$ 27.85
